Abingdon Health PlcLSE: ABDX

Change of Nominated Adviser and Broker

· Issued by Abingdon Health Plc
Watch Abingdon Health explain itABINGDON HEALTH PLC (ABDX) — Interim Results · Replay · Mar 17
Ask Abingdon Health's CEO a questionABINGDON HEALTH PLC (ABDX) — Final results for the year ended 30 June 2026 · Oct 13, 2026 at 10:00 AM UTCRegister

Abingdon Health plc

("Abingdon Health" or "the Company")

Change of Nominated Adviser and Broker

The Company announces its Nominated Adviser and Broker has changed to Zeus Capital Limited with immediate effect.

This change follows completion of the acquisition by Zeus Capital Limited of the WH Ireland Capital Markets Division (from WH Ireland Limited), announced earlier today.

For further information please contact:

Enquiries

Abingdon Health plc

www.abingdonhealth.com/investors/

Chris Yates, Chief Executive Officer

Chris Hand, Non-Executive Chairman

Zeus Capital (Sole Broker and Nominated Adviser)

  Tel: +44 (0) 20 7220 1666

Chris Fielding / Isaac Hooper (Corporate Finance)

Fraser Marshall (Corporate Broking)

The person responsible for arranging the release of this announcement on behalf of the Company is Chris Yates, Chief Executive Officer of the Company.